Xolair 150 MG/ML syringeml
Ended Awarded Last action
- Contract number
- SPE2DR26FCSL5
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $78,961
Award facts
- Contract value 100% obligated
- $78,961.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a $78,961 delivery order to DMS Pharmaceutical Group Inc. on April 14, 2026, for XOLAIR 150 mg/ml syringes under its Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) contract.
DMS Pharmaceutical Group Inc. is a woman-owned small business pharmaceutical wholesaler. Place of performance is Park Ridge, Illinois. The order carries a firm fixed-price structure with an ultimate completion date of May 5, 2026. No set-aside was used.
Quick answers
Who was awarded contract SPE2DR26FCSL5?
SPE2DR26FCSL5 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on April 14, 2026.
How much is contract SPE2DR26FCSL5 worth?
The government has obligated $78,961 on SPE2DR26FCSL5.
Is contract SPE2DR26FCSL5 an order under another contract?
Yes. SPE2DR26FCSL5 is a delivery order under SPE2DR25D9168, an indefinite delivery contract.
Was contract SPE2DR26FCSL5 competed?
The extent of competition for SPE2DR26FCSL5 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award